首页>
外国专利>
CHIMERIC ANTIGEN RECEPTORS (CAR)-EXPRESSING CELLS AND COMBINATION TREATMENT FOR IMMUNOTHERAPY OF PATIENTS WITH RELAPSE REFRACTORY ADVERSE GENETIC RISK AML
CHIMERIC ANTIGEN RECEPTORS (CAR)-EXPRESSING CELLS AND COMBINATION TREATMENT FOR IMMUNOTHERAPY OF PATIENTS WITH RELAPSE REFRACTORY ADVERSE GENETIC RISK AML
The present invention relates to compositions comprising engineered allogenic immune cells endowed with Chimeric Antigen Receptors (CAR), in particular a CAR specific for CD123 and CLL1 for treating AML patients with adverse genetic risk.
展开▼